{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:31:01Z","timestamp":1761406261381,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72304011","82304245","72304009"],"award-info":[{"award-number":["72304011","82304245","72304009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.thromres.2025.109417","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T16:34:01Z","timestamp":1754066041000},"page":"109417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anticoagulation therapy for patients with atrial fibrillation at primary care facilities in Beijing, China, 2017\u20132022"],"prefix":"10.1016","volume":"253","author":[{"given":"Mengyuan","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kexin","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huangqianyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luwen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2025.109417_bb0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"author":"Chinese Society of Pacing and Electrophysiology","key":"10.1016\/j.thromres.2025.109417_bb0010"},{"key":"10.1016\/j.thromres.2025.109417_bb0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jgs.16178","article-title":"Geriatric elements and oral anticoagulant prescribing in older atrial fibrillation patients: SAGE-AF","volume":"68","author":"Saczynski","year":"2020","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.thromres.2025.109417_bb0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/euac153","article-title":"Contemporary management of atrial fibrillation in primary and secondary care in the UK: the prospective long-term AF-GEN-UK Registry","volume":"25","author":"Shantsila","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.thromres.2025.109417_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1160\/TH15-04-0350","article-title":"Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC","volume":"115","author":"Martinez","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109417_bb0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/heartjnl-2022-321377","article-title":"Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014-2019)","volume":"109","author":"Joy","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2025.109417_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ahj.2018.03.003","article-title":"Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk","volume":"200","author":"Lubitz","year":"2018","journal-title":"Am. Heart J."},{"key":"10.1016\/j.thromres.2025.109417_bb0040","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13457","article-title":"Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillation","volume":"51","author":"Bezabhe","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.thromres.2025.109417_bb0045","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/heartjnl-2017-312720","article-title":"Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure","volume":"104","author":"Savarese","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2025.109417_bb0050","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.12659\/MSM.915875","article-title":"Long-term persistence with newly-initiated warfarin or non-VKA oral anticoagulant (NOAC) in patients with non-Valvular atrial fibrillation: insights from the prospective China-AF Registry","volume":"25","author":"Liu","year":"2019","journal-title":"Med. Sci. Monit."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:29:20Z","timestamp":1761406160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825001677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":10,"alternative-id":["S0049384825001677"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109417","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation therapy for patients with atrial fibrillation at primary care facilities in Beijing, China, 2017\u20132022","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109417"}}